These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37183657)

  • 21. Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment.
    Xue M; Zhu Y; Jiang Y; Han L; Shi M; Su R; Wang L; Xiong C; Wang C; Wang T; Deng S; Wu D; Cao Y; Dong L; Bai F; Zhao S; Deng X; Peng C; Li H; Chen J; Shen B; Jiang L; Chen H
    Nat Commun; 2023 Jul; 14(1):4600. PubMed ID: 37524695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK.
    Toste PA; Nguyen AH; Kadera BE; Duong M; Wu N; Gawlas I; Tran LM; Bikhchandani M; Li L; Patel SG; Dawson DW; Donahue TR
    Mol Cancer Res; 2016 May; 14(5):437-47. PubMed ID: 26979711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts.
    Novák Š; Kolář M; Szabó A; Vernerová Z; Lacina L; Strnad H; Šáchová J; Hradilová M; Havránek J; Španko M; Čoma M; Urban L; Kaňuchová M; Melegová N; Gürlich R; Dvořák J; Smetana K; Gál P; Szabo P
    Cancer Genomics Proteomics; 2021; 18(3):221-243. PubMed ID: 33893076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment.
    Boyd LNC; Andini KD; Peters GJ; Kazemier G; Giovannetti E
    Semin Cancer Biol; 2022 Jul; 82():184-196. PubMed ID: 33737108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology.
    Feldmann K; Maurer C; Peschke K; Teller S; Schuck K; Steiger K; Engleitner T; Öllinger R; Nomura A; Wirges N; Papargyriou A; Jahan Sarker RS; Ranjan RA; Dantes Z; Weichert W; Rustgi AK; Schmid RM; Rad R; Schneider G; Saur D; Reichert M
    Gastroenterology; 2021 Jan; 160(1):346-361.e24. PubMed ID: 33007300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decoding Metabolic Symbiosis between Pancreatic Cancer Cells and Cancer-Associated Fibroblasts Using Cultured Tumor Microenvironment.
    Nihashi Y; Song X; Yamamoto M; Setoyama D; Kida YS
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma.
    Pan X; Zhou J; Xiao Q; Fujiwara K; Zhang M; Mo G; Gong W; Zheng L
    J Hematol Oncol; 2021 Nov; 14(1):184. PubMed ID: 34727952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
    Awaji M; Saxena S; Wu L; Prajapati DR; Purohit A; Varney ML; Kumar S; Rachagani S; Ly QP; Jain M; Batra SK; Singh RK
    FASEB J; 2020 Jul; 34(7):9405-9418. PubMed ID: 32453916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer.
    Belle JI; Sen D; Baer JM; Liu X; Lander VE; Ye J; Sells BE; Knolhoff BL; Faiz A; Kang LI; Qian G; Fields RC; Ding L; Kim H; Provenzano PP; Stewart SA; DeNardo DG
    Cancer Discov; 2024 Jul; 14(7):1324-1355. PubMed ID: 38683144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-17A-producing CD8
    Picard FSR; Lutz V; Brichkina A; Neuhaus F; Ruckenbrod T; Hupfer A; Raifer H; Klein M; Bopp T; Pfefferle PI; Savai R; Prinz I; Waisman A; Moos S; Chang HD; Heinrich S; Bartsch DK; Buchholz M; Singh S; Tu M; Klein L; Bauer C; Liefke R; Burchert A; Chung HR; Mayer P; Gress TM; Lauth M; Gaida M; Huber M
    Gut; 2023 Aug; 72(8):1510-1522. PubMed ID: 36759154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer.
    Dings MPG; Manoukian P; Waasdorp C; Quik JSE; Strijker M; Lodestijn SC; van Neerven SM; Moreno LF; de Oliveira RL; Bonsing BA; Bruno MJ; Busch OR; Doukas M; van Eijck CH; Mohammad NH; de Hingh IH; Molenaar QI; Besselink MG; Vermeulen L; Medema JP; van Laarhoven HWM; Bijlsma MF
    Int J Cancer; 2023 Feb; 152(3):511-523. PubMed ID: 36069222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin 1α sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts.
    Tjomsland V; Spångeus A; Välilä J; Sandström P; Borch K; Druid H; Falkmer S; Falkmer U; Messmer D; Larsson M
    Neoplasia; 2011 Aug; 13(8):664-75. PubMed ID: 21847358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer.
    Huang H; Brekken RA
    Am J Physiol Cell Physiol; 2020 Aug; 319(2):C233-C243. PubMed ID: 32432930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
    Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
    Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal Lineage Heterogeneity Underlies Nonredundant Functions of Pancreatic Cancer-Associated Fibroblasts.
    Helms EJ; Berry MW; Chaw RC; DuFort CC; Sun D; Onate MK; Oon C; Bhattacharyya S; Sanford-Crane H; Horton W; Finan JM; Sattler A; Makar R; Dawson DW; Xia Z; Hingorani SR; Sherman MH
    Cancer Discov; 2022 Feb; 12(2):484-501. PubMed ID: 34548310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
    Zhang T; Ren Y; Yang P; Wang J; Zhou H
    Cell Death Dis; 2022 Oct; 13(10):897. PubMed ID: 36284087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblasts in pancreatic cancer: molecular and clinical perspectives.
    Rebelo R; Xavier CPR; Giovannetti E; Vasconcelos MH
    Trends Mol Med; 2023 Jun; 29(6):439-453. PubMed ID: 37100646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1/IGF1R Signaling under Hypoxia.
    Hirakawa T; Yashiro M; Doi Y; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Kimura K; Amano R; Hirakawa K
    PLoS One; 2016; 11(8):e0159912. PubMed ID: 27487118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma.
    Croft W; Pearce H; Margielewska-Davies S; Lim L; Nicol SM; Zayou F; Blakeway D; Marcon F; Powell-Brett S; Mahon B; Merard R; Zuo J; Middleton G; Roberts K; Brown RM; Moss P
    Elife; 2023 Jun; 12():. PubMed ID: 37350578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors.
    Djurec M; Graña O; Lee A; Troulé K; Espinet E; Cabras L; Navas C; Blasco MT; Martín-Díaz L; Burdiel M; Li J; Liu Z; Vallespinós M; Sanchez-Bueno F; Sprick MR; Trumpp A; Sainz B; Al-Shahrour F; Rabadan R; Guerra C; Barbacid M
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1147-E1156. PubMed ID: 29351990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.